生脉注射液治疗缺血性中风的临床疗效评价 ——12个相关研究的Meta分析

孙梁; 孙晨; 张根明

您当前的位置：

首页 >

文章列表页 >

生脉注射液治疗缺血性中风的临床疗效评价 ——12个相关研究的Meta分析

更新时间：2024-01-04

- 生脉注射液治疗缺血性中风的临床疗效评价 ——12个相关研究的Meta分析
- Effectiveness of Shengmai Injection for Ischemic Stroke—a Meta-analysis for 12 Relative Studies
- 中国实验方剂学杂志 2012年18卷第24期页码：5-8
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号：
- 纸质出版日期：2012
- 稿件说明：
移动端阅览
孙梁, 孙晨, 张根明. 生脉注射液治疗缺血性中风的临床疗效评价 ——12个相关研究的Meta分析[J]. 中国实验方剂学杂志, 2012,18(24):5-8.

SUN Liang, SUN Chen, ZHANG Gen-ming. Effectiveness of Shengmai Injection for Ischemic Stroke—a Meta-analysis for 12 Relative Studies[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(24): 5-8.
孙梁, 孙晨, 张根明. 生脉注射液治疗缺血性中风的临床疗效评价 ——12个相关研究的Meta分析[J]. 中国实验方剂学杂志, 2012,18(24):5-8. DOI：

SUN Liang, SUN Chen, ZHANG Gen-ming. Effectiveness of Shengmai Injection for Ischemic Stroke—a Meta-analysis for 12 Relative Studies[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(24): 5-8. DOI：

摘要

目的: 系统评价生脉注射液治疗缺血性中风的临床疗效。方法: 收集生脉注射液治疗缺血性中风的随机、对照临床试验文献

按Meta分析要求对原始文献进行质量评估

对符合条件的有效数据进行Meta分析。计算治疗组与对照组的相对危险度(relative risk RR)

评价生脉注射液治疗缺血性中风的临床疗效。结果: 符合纳入标准的文献共12篇

总样本量960例

其中生脉组493例

有效444例

对照组467例

有效351例

合并RR=1.20

95%可信区间为(1.13

1.27)。结论: 生脉注射液治疗缺血性中风

可改善患者神经功能缺损

疗效优于未使用生脉注射液组。

Abstract

Objective:To conduct a review to explore the efficacy of Shengmai injection in treating ischemic stroke. Method: All randomized controlled trails (RCTs) with regard to the effectiveness of the Shengmai injection for ischemic stroke were collected. The trails were analyzed and evaluated strictly by means of meta-analysis. The relative risk (RR) for effective rate of the Shengmai Injection for ischemic stroke was calculated. Result: Totally 12 RCTs including 960 cases were analyzed. The cumulative cases employed Shengmai Injection for ischemic stroke were 493

in which 444 cases were effective

while in control groups the cases treated without Shengmai injection was 467

in which 351 were effective. The pooled RR was 1.20

with a 95% confidence interval of 1.13 to 1.27. Conclusion: Shengmai injection is effective for ischemic stroke and better than the control treatment

and it can improve the defects in nervous function.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

生脉注射液治疗缺血性中风的临床疗效评价——12个相关研究的Meta分析

缺血性中风脾肾两虚证诊断标准

基于蛋白质组学的生脉注射液抗脑缺血作用机制

定志小丸对卒中后认知障碍模型小鼠PI3K/Akt/mTOR/HIF-1α通路的影响